AU2001249549A1 - Compositions and methods for the therapy and diagnosis of prostate cancer - Google Patents
Compositions and methods for the therapy and diagnosis of prostate cancerInfo
- Publication number
- AU2001249549A1 AU2001249549A1 AU2001249549A AU4954901A AU2001249549A1 AU 2001249549 A1 AU2001249549 A1 AU 2001249549A1 AU 2001249549 A AU2001249549 A AU 2001249549A AU 4954901 A AU4954901 A AU 4954901A AU 2001249549 A1 AU2001249549 A1 AU 2001249549A1
- Authority
- AU
- Australia
- Prior art keywords
- diagnosis
- therapy
- compositions
- methods
- prostate cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Applications Claiming Priority (23)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53685700A | 2000-03-27 | 2000-03-27 | |
US09/536,857 | 2000-03-27 | ||
US56810000A | 2000-05-09 | 2000-05-09 | |
US09/568,100 | 2000-05-09 | ||
US09/570,737 US7202342B1 (en) | 1999-11-12 | 2000-05-12 | Compositions and methods for the therapy and diagnosis of prostate cancer |
US09/570,737 | 2000-05-12 | ||
US09/593,793 US7517952B1 (en) | 1997-02-25 | 2000-06-13 | Compositions and methods for the therapy and diagnosis of prostate cancer |
US09/593,793 | 2000-06-13 | ||
US60578300A | 2000-06-27 | 2000-06-27 | |
US09/605,783 | 2000-06-27 | ||
US09/636,215 US6620922B1 (en) | 1997-02-25 | 2000-08-09 | Compositions and methods for the therapy and diagnosis of prostate cancer |
US09/636,215 | 2000-08-10 | ||
US09/651,236 US6818751B1 (en) | 1997-08-01 | 2000-08-29 | Compositions and methods for the therapy and diagnosis of prostate cancer |
US09/651,236 | 2000-08-29 | ||
US09/657,279 | 2000-09-06 | ||
US09/657,279 US6894146B1 (en) | 1997-02-25 | 2000-09-06 | Compositions and methods for the therapy and diagnosis of prostate cancer |
US09/679,426 | 2000-10-02 | ||
US09/679,426 US6759515B1 (en) | 1997-02-25 | 2000-10-02 | Compositions and methods for the therapy and diagnosis of prostate cancer |
US09/685,166 US6630305B1 (en) | 1999-11-12 | 2000-10-10 | Compositions and methods for the therapy and diagnosis of prostate cancer |
US09/685,166 | 2000-10-10 | ||
US70972900A | 2000-11-09 | 2000-11-09 | |
US09/709,729 | 2000-11-09 | ||
PCT/US2001/009919 WO2001073032A2 (en) | 2000-03-27 | 2001-03-27 | Compositions and methods for the therapy and diagnosis of prostate cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001249549A1 true AU2001249549A1 (en) | 2001-10-08 |
Family
ID=27582800
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001249549A Abandoned AU2001249549A1 (en) | 2000-03-27 | 2001-03-27 | Compositions and methods for the therapy and diagnosis of prostate cancer |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1311673A2 (en) |
JP (1) | JP2004504808A (en) |
AU (1) | AU2001249549A1 (en) |
CA (1) | CA2403909A1 (en) |
WO (1) | WO2001073032A2 (en) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030185830A1 (en) * | 1997-02-25 | 2003-10-02 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US7517952B1 (en) | 1997-02-25 | 2009-04-14 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
WO1998045420A1 (en) | 1997-04-10 | 1998-10-15 | Diagnocure Inc. | Pca3, pca3 genes, and methods of use |
US7037667B1 (en) | 1998-06-01 | 2006-05-02 | Agensys, Inc. | Tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
US20030149531A1 (en) | 2000-12-06 | 2003-08-07 | Hubert Rene S. | Serpentine transmembrane antigens expressed in human cancers and uses thereof |
US6833438B1 (en) | 1999-06-01 | 2004-12-21 | Agensys, Inc. | Serpentine transmembrane antigens expressed in human cancers and uses thereof |
JP4855577B2 (en) | 1998-06-01 | 2012-01-18 | アジェンシス,インコーポレイテッド | Novel serpentine transmembrane antigen expressed in human cancer and use thereof |
US6943235B1 (en) | 1999-04-12 | 2005-09-13 | Agensys, Inc. | Transmembrane protein expressed in prostate cancer |
CA2385477C (en) | 1999-09-29 | 2009-11-03 | Diagnocure Inc. | Pca3 messenger rna species in benign and malignant prostate tissues |
US7361338B2 (en) | 1999-10-05 | 2008-04-22 | Agensys, Inc. | Methods to inhibit growth of prostate cancer cells |
US6790631B1 (en) | 1999-10-05 | 2004-09-14 | Agensys, Inc. | G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
US7208280B2 (en) | 1999-10-05 | 2007-04-24 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer |
EP1517913B9 (en) * | 1999-10-07 | 2007-08-29 | Corixa Corporation | A mycobacterium tuberculosis coding sequence for exression of heterologous proteins |
DE60139963D1 (en) | 2000-06-20 | 2009-10-29 | Corixa Corp | FUSION PROTEINS FROM MYCOBACTERIUM TUBERCULOSIS |
US7776523B2 (en) | 2000-12-07 | 2010-08-17 | Novartis Vaccines And Diagnostics, Inc. | Endogenous retroviruses up-regulated in prostate cancer |
WO2002083921A2 (en) | 2001-04-10 | 2002-10-24 | Agensys, Inc. | Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers |
JP2005504513A (en) * | 2001-05-09 | 2005-02-17 | コリクサ コーポレイション | Compositions and methods for treatment and diagnosis of prostate cancer |
AU2002309873B2 (en) * | 2001-05-15 | 2007-10-18 | Agensys, Inc. | Nucleic acids and corresponding proteins entitled 101P3A11 or PHOR-1 useful in treatment and detection of cancer |
US6897024B2 (en) | 2001-05-31 | 2005-05-24 | Stichting Katholieke Universiteit More Particularly The University Medical Centre Nijmegen | Nucleic acid molecules comprising the promoter for PCA3, and uses thereof |
US7332290B2 (en) | 2001-08-02 | 2008-02-19 | The Regents Of The University Of Michigan | Dectection of AMACR cancer markers in urine |
US7700293B2 (en) | 2001-08-02 | 2010-04-20 | The Regents Of The University Of Michigan | Expression profile of prostate cancer |
US7229774B2 (en) | 2001-08-02 | 2007-06-12 | Regents Of The University Of Michigan | Expression profile of prostate cancer |
US7494646B2 (en) | 2001-09-06 | 2009-02-24 | Agensys, Inc. | Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
EP2287186B1 (en) | 2001-09-06 | 2014-12-31 | Agensys, Inc. | Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
US7371841B2 (en) | 2002-01-25 | 2008-05-13 | Regents Of The University Of California | Methods of modulating cold sensory perception |
WO2003104272A1 (en) * | 2002-06-11 | 2003-12-18 | Glaxosmithkline Biologicals S.A. | Immunogenic compositions |
AU2003243151A1 (en) | 2002-08-16 | 2004-03-03 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer |
ES2427853T3 (en) | 2003-02-07 | 2013-11-04 | Diagnocure Inc. | Procedure to detect prostate cancer in a sample |
MXPA06012187A (en) | 2004-04-22 | 2007-03-28 | Agensys Inc | Antibodies and molecules derived therefrom that bind to steap-1 proteins. |
CA2491067A1 (en) | 2004-12-24 | 2006-06-24 | Stichting Katholieke Universiteit | Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer |
WO2006134917A1 (en) * | 2005-06-14 | 2006-12-21 | Dnavec Corporation | Method for production of antibody |
BRPI0616211A2 (en) | 2005-09-19 | 2011-06-14 | Veridex Llc | Methods for the diagnosis of pancreatic cancer |
US7622573B2 (en) * | 2006-01-17 | 2009-11-24 | Biolex, Inc. | Expression control elements from the lemnaceae family |
US7820174B2 (en) | 2006-02-24 | 2010-10-26 | The United States Of America As Represented By The Department Of Health And Human Services | T cell receptors and related materials and methods of use |
WO2007100568A2 (en) * | 2006-02-24 | 2007-09-07 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | T cell receptors and related materials and methods of use |
KR101541550B1 (en) | 2006-10-27 | 2015-08-04 | 제넨테크, 인크. | Antibodies and immunoconjugates and uses therefor |
GB201513921D0 (en) * | 2015-08-05 | 2015-09-23 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers |
PE20200010A1 (en) | 2017-04-03 | 2020-01-06 | Hoffmann La Roche | ANTIBODIES THAT JOIN STEAP-1 |
WO2024052922A1 (en) * | 2022-09-11 | 2024-03-14 | Yeda Research And Development Co. Ltd. | Anti-klk4 antibodies and uses thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0976699A4 (en) * | 1997-02-19 | 2009-06-03 | Chisso Asahi Fertilizer | Granular fertilizer coated with decomposable coating film and process for producing the same |
US6887660B2 (en) * | 1997-02-25 | 2005-05-03 | Corixa Corporation | Compounds for immunodiagnosis of prostate cancer and methods for their use |
US20030185830A1 (en) * | 1997-02-25 | 2003-10-02 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
TR200100916T2 (en) * | 1998-07-14 | 2002-06-21 | Corixa@@Corporation | |
AU7994200A (en) * | 1999-10-04 | 2001-05-10 | Corixa Corporation | Compositions and methods for therapy and diagnosis of prostate cancer |
CA2391369A1 (en) * | 1999-11-12 | 2001-05-17 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
KR20030016217A (en) * | 2000-01-14 | 2003-02-26 | 코릭사 코포레이션 | Compositions and methods for the therapy and diagnosis of prostate cancer |
JP2005504513A (en) * | 2001-05-09 | 2005-02-17 | コリクサ コーポレイション | Compositions and methods for treatment and diagnosis of prostate cancer |
-
2001
- 2001-03-27 JP JP2001570749A patent/JP2004504808A/en active Pending
- 2001-03-27 EP EP01922786A patent/EP1311673A2/en not_active Withdrawn
- 2001-03-27 CA CA002403909A patent/CA2403909A1/en not_active Abandoned
- 2001-03-27 AU AU2001249549A patent/AU2001249549A1/en not_active Abandoned
- 2001-03-27 WO PCT/US2001/009919 patent/WO2001073032A2/en active Search and Examination
Also Published As
Publication number | Publication date |
---|---|
CA2403909A1 (en) | 2001-10-04 |
WO2001073032A3 (en) | 2003-03-13 |
EP1311673A2 (en) | 2003-05-21 |
JP2004504808A (en) | 2004-02-19 |
WO2001073032A2 (en) | 2001-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001249549A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
AU1656501A (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
HUP0203968A3 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
EP1515982A4 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
AU7994200A (en) | Compositions and methods for therapy and diagnosis of prostate cancer | |
AU2003302892A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
AU2001265296A1 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
AU2001268259A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2001269766A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2001261007A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
AU2002251841A1 (en) | Compositions and methods for the therapy and diagnosis of pancreatic cancer | |
AU2002218770A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
AU2001280982A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2002254482A1 (en) | Compositions and methods for the therapy and diagnosis of kidney cancer | |
AU2002303219A1 (en) | Compositions and methods for the therapy and diagnosis of cancer | |
AU2001252945A1 (en) | Compositions and methods for therapy and diagnosis of colon cancer | |
AU2002246519A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2001259062A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
AU2002239431A1 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
AU2001290518A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2002313726A1 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
AU5638400A (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
AU3483001A (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
AU2001273149A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
AU2001249317A1 (en) | Compositions and methods for the therapy and diagnosis of ovarian and endometrial cancer |